Biocardia Inc (BCDA)

May 23, 2026

BioCardia outlines Japan Shonin filing in ~7 months and targets ~19-month path to approval for CardiAMP - MSN

May 23, 2026

May 21, 2026

BioCardia CEO Peter Altman buys $1,570 in company stock - Investing.com

May 21, 2026

May 21, 2026

BioCardia (NASDAQ: BCDA) CEO adds 1,700 shares in May open‑market buys - Stock Titan

May 21, 2026

May 21, 2026

BioCardia reports positive results from CardiAMP CMI trial By Investing.com - Investing.com Nigeria

May 21, 2026

May 21, 2026

BioCardia Announces Positive CardiAMP Chronic Myocardial Ischemia Trial Results with Reduced Angina at EuroPCR 2026 - Minichart

May 21, 2026

May 21, 2026

BioCardia reports positive results from CardiAMP CMI trial - Investing.com UK

May 21, 2026

May 21, 2026

BioCardia Announces Encouraging CardiAMP Chronic Ischemia Data - TipRanks

May 21, 2026

May 21, 2026

BioCardia reports durable exercise gains, 82% angina reduction in CardiAMP CMI open-label cohort - TradingView

May 21, 2026

May 21, 2026

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency - The Manila Times

May 21, 2026

May 21, 2026

BioCardia (NASDAQ: BCDA) posts CardiAMP CMI data with durable angina and exercise gains - Stock Titan

May 21, 2026

May 21, 2026

Heart cell therapy linked to longer walks, 82% fewer angina attacks - Stock Titan

May 21, 2026

May 19, 2026

BioCardia president and CEO Peter Altman buys $5,244 in stock By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

BioCardia, Inc. (NASDAQ:BCDA) Q1 2026 Earnings Call Transcript - Insider Monkey

May 19, 2026

May 19, 2026

BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - The Manila Times

May 19, 2026

May 19, 2026

Watch BioCardia’s virtual fireside chat at A.G.P. healthcare showcase - Stock Titan

May 19, 2026

May 19, 2026

BioCardia Reports Promising CardiAMP Cell Therapy Data in Q1 2026 Conference Call - IndexBox

May 19, 2026

May 18, 2026

BioCardia president and CEO Peter Altman buys $5,244 in stock - Investing.com UK

May 18, 2026

May 18, 2026

BioCardia (BCDA) CEO buys 5,700 shares in open-market purchase - Stock Titan

May 18, 2026

May 18, 2026

BioCardia (BCDA) Q1 2026 Earnings Transcript - AOL.com

May 18, 2026

May 18, 2026

BioCardia Q1 2026: -$0.21 EPS Falls Short — Deep Dive - AlphaStreet

May 18, 2026

May 18, 2026

BCDA Stock Price, Quote & Chart | BIOCARDIA INC (NASDAQ:BCDA) - ChartMill

May 18, 2026

May 16, 2026

Q1 2026 BioCardia Inc Earnings Call Transcript - GuruFocus

May 16, 2026

May 16, 2026

BioCardia, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 16, 2026

May 16, 2026

BioCardia Inc (BCDA) Q1 2026 Earnings Call Highlights: Breakthroughs in Cardiac Therapy and ... By GuruFocus - Investing.com Canada

May 16, 2026

May 16, 2026

Key facts: CardiAMP advances in US, Japan; FDA flags two Helix paths - TradingView

May 16, 2026

May 16, 2026

BioCardia (BCDA) Q1 2026: EPS Not Disclosed, Revenue Not Disclos - GuruFocus

May 16, 2026

May 16, 2026

BioCardia Inc (BCDA) Q1 2026 Earnings Call Highlights: Breakthro - GuruFocus

May 16, 2026

May 15, 2026

Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus

May 15, 2026

May 15, 2026

Earnings call transcript: Biocardia Q1 2026 highlights clinical progress By Investing.com - Investing.com Nigeria

May 15, 2026

May 15, 2026

BioCardia CEO Peter Altman buys $5,202 in company stock - Investing.com

May 15, 2026

May 15, 2026

BioCardia CEO Peter Altman buys $5,202 in company stock By Investing.com - Investing.com South Africa

May 15, 2026

May 15, 2026

BCDA: CardiAMP therapy advances toward Japanese approval, targeting a $400M market with strong clinical data - TradingView

May 15, 2026

May 15, 2026

Earnings call transcript: Biocardia Q1 2026 highlights clinical progress - Investing.com UK

May 15, 2026

May 15, 2026

BioCardia (BCDA) CEO Peter Altman makes open-market stock purchase - Stock Titan

May 15, 2026

May 15, 2026

BioCardia Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2026

May 15, 2026

BioCardia Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 15, 2026

May 15, 2026

BCDA - Finviz

May 15, 2026

May 15, 2026

MSN Money - MSN

May 15, 2026

May 15, 2026

BioCardia Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026

May 15, 2026

BioCardia, Inc. (BCDA) Files Form 8-K: Financial Results, SEC Disclosures, and NASDAQ Listing for May 2026 - Minichart

May 15, 2026

May 15, 2026

BioCardia Inc (NASDAQ:BCDA) Q1 Earnings Miss Overshadows Clinical Progress - ChartMill

May 15, 2026

May 15, 2026

BIOCARDIA ($BCDA) Releases Q1 2026 Earnings - Quiver Quantitative

May 15, 2026

May 15, 2026

BioCardia reports Q1 2026 net loss of $2.3M, cash $951K and ongoing regulatory progress - TradingView

May 15, 2026

May 15, 2026

BCDA: Advanced regulatory milestones and improved financials, but cash reserves declined - TradingView

May 15, 2026

May 15, 2026

BioCardia, Inc. 1Q 2026: Net loss $(2.26)M, EPS $(0.21) — 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

BioCardia, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026